| scholarly article | Q13442814 |
| P50 | author | Hans-Peter Hartung | Q30001859 |
| P2093 | author name string | Schäfer B | |
| Toyka KV | |||
| Heininger K | |||
| Fierz W | |||
| P2860 | cites work | Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis | Q46829147 |
| Axonal degeneration in demyelinating disorders | Q46850016 | ||
| Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome | Q48110038 | ||
| Complement depletion suppresses Lewis rat experimental allergic neuritis | Q48213261 | ||
| Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy | Q48224609 | ||
| Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups | Q48434658 | ||
| The neuropathy of plasma cell dyscrasia: binding of IgM M-proteins to peripheral nerve glycolipids | Q48451785 | ||
| The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system | Q48565370 | ||
| Tissue culture demyelination by normal human serum | Q48659082 | ||
| Cultured human and rat oligodendrocytes and rat schwann cells do not have immune response gene associated antigen (Ia) on their surface | Q48704110 | ||
| Blood-nerve barrier studies in experimental allergic neuritis | Q50918753 | ||
| Ultrastructural and histophysiological studies on the blood-nerve barrier and perineurial barrier in leprosy neuropathy | Q50925963 | ||
| Conduction block in rat myelinated fibres following acute exposure to anti-galactocerebroside serum | Q51862864 | ||
| Suppression of experimental allergic neuritis by Cyclosporin-A. | Q53929186 | ||
| Motor conduction studies in Guillain-Barré syndrome: description and prognostic value | Q54546275 | ||
| Neuronal antinuclear antibody in sensory neuronopathy from lung cancer | Q55060391 | ||
| Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions | Q57081100 | ||
| T-Lymphocyte subsets, functional deficits, and morphology in sciatic nerves during experimental allergic neuritis | Q57352490 | ||
| In Vivo Treatment of Rats with Monoclonal Anti-T-Cell Antibodies | Q57352857 | ||
| Dynamics of Ia-expressing cells and T lymphocytes of different subsets during experimental allergic neuritis in Lewis rats | Q57352926 | ||
| Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination | Q33969713 | ||
| The initial lesion in experimental allergic neuritis. A phase and electron microscopic study | Q36269289 | ||
| Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2. | Q36348332 | ||
| Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. I. Demyelination | Q36574232 | ||
| Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation | Q37677257 | ||
| Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system | Q38172557 | ||
| Humoral factors in peripheral nerve disease | Q38173074 | ||
| Peripheral neuropathy associated with monoclonal IgM autoantibody | Q39180355 | ||
| Treatment of the neuromuscular complications of human immunodeficiency virus infection | Q39187378 | ||
| Induction of experimental allergic neuritis with a peptide from myelin P2 basic protein | Q39450989 | ||
| Peripheral neuropathies associated with monoclonal proteins: a clinical review | Q39497353 | ||
| Controlled trial prednisolone in acute polyneuropathy | Q39507716 | ||
| A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies | Q39508131 | ||
| The use of steroids in the treatment of idiopathic polyneuritis | Q39975557 | ||
| Demyelination in allergic and Marke's disease virus induced neuritis comparative electron microscopic studies | Q40115495 | ||
| Identification of the neuritogen for experimental allergic neuritis | Q40699380 | ||
| Inflammatory neuropathy in homosexual men with lymphadenopathy | Q40815144 | ||
| Plasma proteins in human peripheral nerve | Q40839889 | ||
| Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor | Q41244469 | ||
| Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment | Q41475082 | ||
| Serum antibodies to gangliosides in Guillain-Barré syndrome | Q42208974 | ||
| Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines | Q43406073 | ||
| Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy | Q43628763 | ||
| HLA typing and Guillain-Barre syndrome | Q43685547 | ||
| The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line | Q43819450 | ||
| The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation | Q43819984 | ||
| Transfer of demyelination by intraneul injection of experimental allergic neuritis serum | Q44090957 | ||
| Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome). | Q44610152 | ||
| Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat. | Q44699936 | ||
| Chronic relapsing demyelinating polyneuropathy associated with hepatitis B infection | Q44747708 | ||
| Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies | Q44880376 | ||
| The Landry-Guillain-barré syndrome. Complications, prognosis and natural history in 123 cases | Q45047426 | ||
| Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells | Q45298273 | ||
| Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection | Q45835179 | ||
| Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics | Q45862823 | ||
| Endoneurial injection of antisera to myelin antigens. | Q45977514 | ||
| Serum-mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome | Q46202428 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 122-161 | |
| P577 | publication date | 1988-01-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Immune mechanisms in inflammatory polyneuropathy | |
| P478 | volume | 540 |
| Q67577854 | Acute axonal idiopathic polyneuropathy: a Guillain-Barré syndrome variant? |
| Q72099047 | Antigalactocerebroside antibody increases demyelination in adoptive transfer experimental allergic neuritis |
| Q41293519 | Autoimmune responses in peripheral nerve |
| Q30392177 | Broken or maladaptive? Altered trajectories in neuroinflammation and behavior after early life adversity |
| Q36961666 | Chronic demyelinating polyneuropathy associated with eosinophilia-myalgia syndrome |
| Q41572248 | Effects of ganglioside administration on experimental autoimmune neuritis induced by peripheral nerve myelin or P2-specific T cell lines |
| Q39739437 | Expression of RhoA by inflammatory macrophages and T cells in rat experimental autoimmune neuritis. |
| Q36994582 | Gangliosides as targets for autoimmune injury to the nervous system |
| Q36480295 | Glomerulonephritis associated with chronic inflammatory demyelinating polyneuropathy |
| Q72768078 | Guillain-Barré syndrome following streptokinase therapy |
| Q40371882 | Guillain-Barré syndrome: clinical and immunological aspects |
| Q34682761 | Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models |
| Q74452553 | Matrix metalloproteinases MMP‐9 and MMP‐7 are expressed in experimental autoimmune neuritis and the guillain‐barré syndrome |
| Q33741209 | Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms |
| Q30495158 | Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system. |
| Q41705902 | Response of the axon and barrier endothelium to experimental allergic neuritis induced by autoreactive T cell lines |
| Q54284373 | T cell vaccination does not induce resistance to experimental autoimmune neuritis |
| Q35229179 | The Use of IVIG in Neurological Disease |
| Q71677219 | Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN |
| Q74103234 | Therapeutic plasma exchange 1996 |
| Q35773773 | Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course |
| Q71376630 | Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies |
Search more.